PCH
Polar Capital Holdings Portfolio holdings
AUM
$19.1B
This Quarter Return
+12.56%
1 Year Return
+55.52%
3 Year Return
+234.94%
5 Year Return
–
10 Year Return
–
AUM
$23M
AUM Growth
+$23M
(-100%)
Cap. Flow
-$596M
Cap. Flow
% of AUM
-2,592.19%
Top 10 Holdings %
Top 10 Hldgs %
41.77%
Holding
385
New
66
Increased
148
Reduced
79
Closed
38
Top Buys
| 1 |
Ferguson
FERG
|
$4.67M |
| 2 |
Marvell Technology
MRVL
|
$232K |
| 3 |
Advanced Micro Devices
AMD
|
$172K |
| 4 |
Meta Platforms (Facebook)
META
|
$134K |
| 5 |
Seagate
STX
|
$127K |
Top Sells
| 1 |
Cadence Design Systems
CDNS
|
$129M |
| 2 |
AdaptHealth
AHCO
|
$70.4M |
| 3 |
SolarEdge
SEDG
|
$54.9M |
| 4 |
Haemonetics
HAE
|
$37.6M |
| 5 |
CCXI
ChemoCentryx, Inc.
CCXI
|
$36.8M |
Sector Composition
| 1 | Technology | 31.33% |
| 2 | Industrials | 21.36% |
| 3 | Healthcare | 15.03% |
| 4 | Communication Services | 12.11% |
| 5 | Financials | 11.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
251
Masimo
MASI
$7.48B
| $5.24K | 0.02% |
21,612
+1,788
| +9% | +$434 |
|
252
Ares Capital
ARCC
$15.7B
| $5.21K | 0.02% |
265,972
+43,502
| +20% | +$852 |
|
253
KLA
KLAC
$112B
| $5.2K | 0.02% |
+16,032
| New | +$5.2K |
|
|
ANSS
254
DELISTED
Ansys
ANSS
| $4.99K | 0.02% |
14,369
-105,745
| -88% | -$36.7K |
|
|
RCM
255
DELISTED
R1 RCM Inc. Common Stock
RCM
| $4.97K | 0.02% |
223,437
+191,013
| +589% | +$4.25K |
|
256
Chemed
CHE
$6.76B
| $4.93K | 0.02% |
10,389
+9,462
| +1,021% | +$4.49K |
|
|
AKYA
257
DELISTED
Akoya BioSciences
AKYA
| $4.84K | 0.02% |
+250,000
| New | +$4.84K |
|
258
CVS Health
CVS
$94B
| $4.83K | 0.02% |
+57,917
| New | +$4.83K |
|
259
AbbVie
ABBV
$374B
| $4.6K | 0.02% |
+40,872
| New | +$4.6K |
|
260
Oracle
ORCL
$633B
| $4.5K | 0.02% |
57,866
| – | – |
|
261
Dollar General
DG
$24.3B
| $4.4K | 0.02% |
20,336
| – | – |
|
262
Coursera
COUR
$1.81B
| $4.35K | 0.02% |
+110,032
| New | +$4.35K |
|
263
Cerus
CERS
$243M
| $4.19K | 0.02% |
+709,718
| New | +$4.19K |
|
|
VERV
264
DELISTED
Verve Therapeutics
VERV
| $3.92K | 0.02% |
+65,000
| New | +$3.92K |
|
265
Stitch Fix
SFIX
$679M
| $3.89K | 0.02% |
64,542
-1,132
| -2% | -$68 |
|
266
Denali Therapeutics
DNLI
$2.26B
| $3.83K | 0.02% |
+48,798
| New | +$3.83K |
|
267
Equifax
EFX
$28.8B
| $3.79K | 0.02% |
+15,808
| New | +$3.79K |
|
|
DNB
268
DELISTED
Dun & Bradstreet
DNB
| $3.26K | 0.01% |
+152,508
| New | +$3.26K |
|
269
LivaNova
LIVN
$3.11B
| $3.01K | 0.01% |
+35,732
| New | +$3.01K |
|
270
O'Reilly Automotive
ORLY
$87.6B
| $2.66K | 0.01% |
4,700
| – | – |
|
271
AngioDynamics
ANGO
$425M
| $2.65K | 0.01% |
+97,626
| New | +$2.65K |
|
272
Penumbra
PEN
$10.5B
| $2.44K | 0.01% |
+8,913
| New | +$2.44K |
|
|
ITCI
273
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $2.39K | 0.01% |
+58,444
| New | +$2.39K |
|
274
Qiagen
QGEN
$10.2B
| $2.38K | 0.01% |
46,522
-63,478
| -58% | -$3.25K |
|
275
General Dynamics
GD
$87.3B
| $2.2K | 0.01% |
11,700
| – | – |
|